Ferroptosis: a new antidepressant pharmacological mechanism

被引:14
作者
Zhang, Guangheng [1 ]
Lv, Shimeng [1 ]
Zhong, Xia [1 ]
Li, Xiangyu [2 ]
Yi, Yunhao [3 ]
Lu, Yitong [1 ]
Yan, Wei [4 ]
Li, Jiamin [4 ]
Teng, Jing [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Dept Clin Med Coll 1, Jinan, Peoples R China
[2] China Acad Chinese Med Sci, Wangjing Hosp, Beijing, Peoples R China
[3] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan, Peoples R China
关键词
ferroptosis; depression; traditional Chinese medicine; pharmacological mechanism; antidepressants; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; SOLUBLE INTERLEUKIN-2; TRANSFERRIN RECEPTOR; MAJOR DEPRESSION; MOUSE MODEL; IRON; GLUTATHIONE; PLASMA; PATHOPHYSIOLOGY;
D O I
10.3389/fphar.2023.1339057
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The incidence rate of depression, a mental disorder, is steadily increasing and has the potential to become a major global disability factor. Given the complex pathological mechanisms involved in depression, the use of conventional antidepressants may lead to severe complications due to their side effects. Hence, there is a critical need to explore the development of novel antidepressants. Ferroptosis, a newly recognized form of cell death, has been found to be closely linked to the onset of depression. Several studies have indicated that certain active ingredients can ameliorate depression by modulating the ferroptosis signaling pathway. Notably, traditional Chinese medicine (TCM) active ingredients and TCM prescriptions have demonstrated promising antidepressant effects in previous investigations owing to their unique advantages in antidepressant therapy. Building upon these findings, our objective was to review recent relevant research and provide new insights and directions for the development and application of innovative antidepressant strategies.
引用
收藏
页数:18
相关论文
共 50 条
[41]   Research progress on the occurrence and therapeutic mechanism of ferroptosis in NSCLC [J].
Zhang, Yifan ;
Guo, Ruixue ;
Li, Jia ;
Zhu, Liangming .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (01) :1-12
[42]   Ferroptosis interaction with inflammatory microenvironments: Mechanism, biology, and treatment [J].
Dou, Jinge ;
Liu, Xiaowei ;
Yang, Lei ;
Huang, Dingming ;
Tan, Xuelian .
BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
[43]   Role of ferroptosis in fibrosis: From mechanism to potential therapy [J].
Qiu, Xuemeng ;
Bi, Qing ;
Wu, Jiyue ;
Sun, Zejia ;
Wang, Wei .
CHINESE MEDICAL JOURNAL, 2024, 137 (07) :806-817
[44]   Research progress on the mechanism of ferroptosis and its clinical application [J].
Xia, Jiarui ;
Si, Huifang ;
Yao, Wu ;
Li, Chao ;
Yang, Guo ;
Tian, Yangyang ;
Hao, Changfu .
EXPERIMENTAL CELL RESEARCH, 2021, 409 (02)
[45]   Ferroptosis: A novel therapeutic strategy and mechanism of action in glioma [J].
Zhang, Gaosen ;
Fang, Yi ;
Li, Xiang ;
Zhang, Zhen .
FRONTIERS IN ONCOLOGY, 2022, 12
[46]   Antidepressant pharmacological mechanisms: focusing on the regulation of autophagy [J].
Lv, Shimeng ;
Zhang, Guangheng ;
Huang, Yufei ;
Li, Jiamin ;
Yang, Ni ;
Lu, Yitong ;
Ma, Haoteng ;
Ma, Yuexiang ;
Teng, Jing .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[47]   Ferroptosis: A New Strategy for Cancer Therapy [J].
Chen, Yu ;
Fan, Zhihua ;
Hu, Shen ;
Lu, Chengchao ;
Xiang, Yi ;
Liao, Shuzhi .
FRONTIERS IN ONCOLOGY, 2022, 12
[48]   Pharmacological Mechanism and Drug Research Prospects of Ginsenoside Rb1 as an Antidepressant [J].
Zhuang, Shuhui ;
Shi, Fuqiang ;
Cannella, Nazzareno ;
Ubaldi, Massimo ;
Ciccocioppo, Roberto ;
Li, Hongwu ;
Qin, Di .
ANTIOXIDANTS, 2025, 14 (02)
[49]   Cell Ferroptosis: New Mechanism and New Hope for Retinitis Pigmentosa [J].
Yang, Ming ;
So, Kwok-Fai ;
Lam, Wai-Ching ;
Lo, Amy Cheuk Yin .
CELLS, 2021, 10 (08)
[50]   Research Progresss on Mechanism of Ferroptosis [J].
Zhou Wen-Bo ;
Kong Chen-Fei ;
Qin Gao-Wei ;
Wang Yuan-Yuan ;
Liu Xin ;
Wang Xiao-Feng .
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2018, 45 (01) :16-22